[1] Univ Paris Saclay, Drug Dev Dept DITEP, Gustave Roussy, Villejuif, France
[2] Ctr Georges Francois Leclerc, Unite Phases Precoces, Dijon, France
[3] Hosp Civils Lyon, CITOHL, Inst Cancerol, Lyon, France
[4] Hop Cochin, Paris, France
[5] CHU Caen, Ctr Rech Clin, Essais Phases Precoces, Caen, France
[6] Gustave Roussy, Translat Res Lab, Villejuif, France
[7] FV Clin Subcontractor SynteractHCR SAS, Levallois Perret, France
[8] Ys Therapeut Inc, Redwood City, CA USA
[9] Kissei Pharmaceut Co Ltd, Tokyo, Japan
[10] Univ Tokyo, Inst Med Sci, IMSUT Hosp, Dept Rheumatol & Allergy, Tokyo, Japan
[11] Univ Florida, Div Hematol Oncol, Gainesville, FL USA
[12] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan
[13] Keio Univ, Sch Med, Tokyo, Japan
[14] Saitama Med Univ, Saitama, Japan
[15] Ys AC Co Ltd, Tokyo, Japan